Other News To Note
Tuesday, March 5, 2013
Amicus Therapeutics Inc., of Cranbury, N.J., said it introduced chaperone-advanced replacement therapy (CHART) as the brand name for its technology platform that combines pharmacological chaperones with enzyme replacement therapy or lysosomal storage diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.